Dostarlimab (Anti-PDCD1 / PD-1 / CD279)
Dostarlimab (Anti-PDCD1 / PD-1 / CD279) (A2835-GRP)
Products
Description
Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1Â programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2835 |
| Target | PD-1/PD-L1 |